APC and colonic neoplasm: Overall, loss-of-function mutations in the APC (adenomatous polyposis coli) tumour suppressor gene or oncogenic mutations in β-catenin (CTNNB1) lead to the constitutive activation of Wnt/β-catenin signalling and represents the most common rate limiting (adenoma-forming) events among colon cancer patients.